NO310772B1 - (R)-(-)-metylfenyloksazolidinon-derivater, fremgangsmåte for fremstilling derav, og anvendelse av disse for fremstilling av etlegemiddel - Google Patents

(R)-(-)-metylfenyloksazolidinon-derivater, fremgangsmåte for fremstilling derav, og anvendelse av disse for fremstilling av etlegemiddel Download PDF

Info

Publication number
NO310772B1
NO310772B1 NO19981688A NO981688A NO310772B1 NO 310772 B1 NO310772 B1 NO 310772B1 NO 19981688 A NO19981688 A NO 19981688A NO 981688 A NO981688 A NO 981688A NO 310772 B1 NO310772 B1 NO 310772B1
Authority
NO
Norway
Prior art keywords
oxazolidinone
methyl
methoxyphenyl
mixture
ethyl acetate
Prior art date
Application number
NO19981688A
Other languages
English (en)
Norwegian (no)
Other versions
NO981688D0 (no
NO981688L (no
Inventor
Henry Laurent
Eckhard Ottow
Gerald Kirsch
Helmut Wachtel
Herbert Schneider
Daryl Faulds
Harald Dinter
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO981688D0 publication Critical patent/NO981688D0/no
Publication of NO981688L publication Critical patent/NO981688L/no
Publication of NO310772B1 publication Critical patent/NO310772B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
NO19981688A 1995-10-20 1998-04-15 (R)-(-)-metylfenyloksazolidinon-derivater, fremgangsmåte for fremstilling derav, og anvendelse av disse for fremstilling av etlegemiddel NO310772B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19540475A DE19540475A1 (de) 1995-10-20 1995-10-20 Chirale Methylphenyloxazolidinone
PCT/DE1996/000259 WO1997015561A1 (de) 1995-10-20 1996-02-09 Chirale methylphenyloxazolidinone

Publications (3)

Publication Number Publication Date
NO981688D0 NO981688D0 (no) 1998-04-15
NO981688L NO981688L (no) 1998-04-15
NO310772B1 true NO310772B1 (no) 2001-08-27

Family

ID=7776217

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981688A NO310772B1 (no) 1995-10-20 1998-04-15 (R)-(-)-metylfenyloksazolidinon-derivater, fremgangsmåte for fremstilling derav, og anvendelse av disse for fremstilling av etlegemiddel

Country Status (24)

Country Link
US (1) US6025376A (pl)
EP (1) EP0859766B1 (pl)
JP (1) JPH11513693A (pl)
KR (1) KR100417359B1 (pl)
CN (1) CN1077103C (pl)
AT (1) ATE201203T1 (pl)
AU (1) AU715344B2 (pl)
CZ (1) CZ292167B6 (pl)
DE (2) DE19540475A1 (pl)
DK (1) DK0859766T3 (pl)
ES (1) ES2158284T3 (pl)
FI (1) FI980862L (pl)
GR (1) GR3036305T3 (pl)
HU (1) HUP9802630A3 (pl)
IL (1) IL117091A (pl)
NO (1) NO310772B1 (pl)
NZ (1) NZ301645A (pl)
PL (1) PL185526B1 (pl)
PT (1) PT859766E (pl)
RU (1) RU2156243C2 (pl)
SK (1) SK282653B6 (pl)
TR (1) TR199800679T2 (pl)
WO (1) WO1997015561A1 (pl)
ZA (1) ZA961074B (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1007038A2 (en) * 1997-08-21 2000-06-14 Takeda Chemical Industries, Ltd. Anti-inflammatory agent
DE19928312A1 (de) * 1999-06-16 2000-12-21 Schering Ag Arzneimittelzubereitung mit verzögerter Wirkstoffabgabe
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
EP1216700A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsysteme (TDS) enthaltend (R)-(-)-Methylphenyloxazolidinon-Derivate, Inhibitoren der Phosphodiesterase IV
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
WO2003002187A2 (en) * 2001-06-26 2003-01-09 Photomed Technologies, Inc. Multiple wavelength illuminator
CA2451955C (en) 2001-06-26 2015-09-29 Abgenix, Inc. Antibodies to opgl
EP2042181A1 (en) * 2002-02-04 2009-04-01 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
WO2004060911A2 (en) * 2002-12-30 2004-07-22 Amgen Inc. Combination therapy with co-stimulatory factors
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
WO2004098592A1 (ja) * 2003-05-06 2004-11-18 Senju Pharmaceutical Co. Ltd. オキサゾリジノン誘導体含有組成物
ES2251866B1 (es) 2004-06-18 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2251867B1 (es) * 2004-06-21 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
ES2320954B1 (es) * 2007-03-02 2010-03-16 Laboratorio Almirall S.A. Nuevo procedimiento de preparacion de 3-metil-4-fenilisoxazolo (3,4-d)iridazin-7(6h)-ona.
US9163044B2 (en) 2011-04-19 2015-10-20 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
WO2013013179A1 (en) 2011-07-21 2013-01-24 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
US11141410B2 (en) 2015-12-16 2021-10-12 Merck Sharp & Dohme Corp Oxazolidinones as taro inhibitors
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
CA3135420A1 (en) * 2018-04-05 2019-10-10 Universiteit Hasselt Selective pde4d inhibitors against demyelinating diseases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
DE2541855A1 (de) * 1975-09-18 1977-03-31 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone ii
FR2358155A1 (fr) * 1976-07-15 1978-02-10 Lapinet Eugene Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses
DE2655369A1 (de) * 1976-12-03 1978-06-08 Schering Ag 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung
US5783591A (en) * 1984-10-19 1998-07-21 Schering Aktiengesellschaft Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
DE3438839A1 (de) * 1984-10-19 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische praeparate
DE3639225A1 (de) * 1986-11-14 1988-05-19 Schering Ag Verwendung von 5-(subst. phenyl)-oxazolidinonderiaten als psychopharmaka
WO1991000092A1 (en) * 1989-06-13 1991-01-10 Smithkline Beecham Corporation Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
DE69128627T2 (de) * 1990-08-03 1998-07-02 Smithkline Beecham Corp Philad Tnf-inhibitoren
PT100441A (pt) * 1991-05-02 1993-09-30 Smithkline Beecham Corp Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
US5227369A (en) * 1991-07-11 1993-07-13 The Regents Of The University Of California Compositions and methods for inhibiting leukocyte adhesion to cns myelin
CA2117547A1 (en) * 1992-02-24 1993-09-02 Michiko Watanabe Ice nucleus-forming bacterium, process for cultivation of the same, ice nucleus-forming substance containing the same, and uses of said substance
GB9204808D0 (en) * 1992-03-04 1992-04-15 Rhone Poulenc Rorer Ltd Novel compositions of matter
US5264437A (en) * 1992-03-20 1993-11-23 Syntex (U.S.A.) Inc. Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
US5672622A (en) * 1994-04-21 1997-09-30 Berlex Laboratories, Inc. Treatment of multiple sclerosis

Also Published As

Publication number Publication date
HUP9802630A2 (hu) 1999-04-28
FI980862A0 (fi) 1998-04-17
GR3036305T3 (en) 2001-10-31
TR199800679T2 (xx) 1998-07-21
NO981688D0 (no) 1998-04-15
CZ120198A3 (cs) 1998-07-15
NO981688L (no) 1998-04-15
DE59606920D1 (de) 2001-06-21
CN1077103C (zh) 2002-01-02
KR19990064339A (ko) 1999-07-26
ZA961074B (en) 1997-02-26
CN1200115A (zh) 1998-11-25
HUP9802630A3 (en) 2000-01-28
EP0859766A1 (de) 1998-08-26
WO1997015561A1 (de) 1997-05-01
FI980862A7 (fi) 1998-04-17
DE19540475A1 (de) 1997-04-24
ES2158284T3 (es) 2001-09-01
ATE201203T1 (de) 2001-06-15
SK49598A3 (en) 1998-09-09
PL185526B1 (pl) 2003-05-30
KR100417359B1 (ko) 2004-03-19
EP0859766B1 (de) 2001-05-16
CZ292167B6 (cs) 2003-08-13
NZ301645A (en) 1999-11-29
FI980862L (fi) 1998-04-17
PT859766E (pt) 2001-10-30
HK1015788A1 (en) 1999-10-22
SK282653B6 (sk) 2002-11-06
RU2156243C2 (ru) 2000-09-20
IL117091A (en) 2000-07-26
JPH11513693A (ja) 1999-11-24
DK0859766T3 (da) 2001-08-13
AU715344B2 (en) 2000-01-20
IL117091A0 (en) 1996-06-18
AU4712396A (en) 1997-05-15
PL326322A1 (en) 1998-09-14
US6025376A (en) 2000-02-15

Similar Documents

Publication Publication Date Title
KR100417359B1 (ko) 키랄메틸페닐옥사졸리디논
US8153681B2 (en) Method of treating epilepsy by administering 5-(4{[(2-fluorophenyl)methyl]oxy}phenyl)prolinamide
NO171365B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
JP2000514801A (ja) 抗高血圧、心臓保護、抗乏血及び抗脂肪分解特性を有する化合物
NO141800B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO305951B1 (no) Kjemiske forbindelser, farmasoeytisk preparat med blodplateaggregeringshemmende egenskaper, samt anvendelse av forbindelsene til fremstilling av henholdsvis en blodplateaggregeringsinhibitor og et farmasoeytisk preparat for behandling eller foreby
KR20220004174A (ko) GlyT1 억제제의 고체 형태
DE19615232A1 (de) Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten
DE69031111T2 (de) Indolderivate
DE19707628A1 (de) Oxazolidinone
NO312964B1 (no) (R)-5-brom-N-(1-etyl-4-metylheksahydro-1H-1,4-diazepin-6-yl)- 2-metoksy-6-metylamino-3-pyridinkarboksamid, fremgangsmåte vedfremstilling derav og farmasöytisk sammensetning inneholdendeforbindelsen, samt anvendelse av denne
NZ544006A (en) Substituted diketopiperazines and their pharmaceutical use as oxytocin antagonists
RU2242464C2 (ru) Производные этансульфонилпиперидина и лекарственное средство на их основе
AU688186B2 (en) (Thiophen-2-YL)-piperidin or tetrahydropyridin carboxamides
DE69310567T2 (de) In der 3-Position durch einen gesättigten oder ungesättigten Fettsäurerest substituierte Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel mit Thromboxan-A2 inhibierender Aktivität
NO801627L (no) Hydroxyamino-eburnan-derivater og fremgangsmaate ved deres fremstilling
US8143306B2 (en) Methods of treating bipolar disorders
JP2010502760A (ja) うつ病の治療用の３−アザビシクロ［４．１．０］ヘプタン誘導体
NO762085L (pl)
NO309422B1 (no) Substituerte fenylamidiner og anvendelse derav, samt fysiologisk forenelige salter og legemidler
NO159594B (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive dihydropyridin-3,5-dicarboxylsyreester-derivater.
IE45709B1 (en) Tricyclic compounds
EP4631947A1 (en) Substituted tricyclic ligands for fk506-binding proteins for treatment of diseases
CA2235264C (en) Chiral methylphenyloxazolidinones
NO821698L (no) 3-(2-(tetra- og heksahydro-4-pyridyl)-etyl)-indoler og deres bruk som legemidler